About UCSF Search UCSF UCSF Medical Center

Paul A. Volberding, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
volberding_paul

Professor and Vice Chair, Department of Medicine, UCSF

paul.volberding@med.va.gov

Phone: (415) 750-2037 (voice)
VAMC Bldg 203 1A81
San Francisco, CA 94143-111

View on UCSF Profiles


Education

University of Chicago, BA, 1967-1971, Biology
University of Minnesota, MD, 1971-1975, Medicine
University of Utah Medical Center, Residency, 1975-1978, Internal Medicine
University of California San Francisco, Fellow, 1978-1981, Hematology/Oncology


Professional Experience

  • 1968-1971
    Virology Laboratory Assistant, Dr. Marc Beem, University of Chicago
  • 1971-1975
    University of Minnesota School of Medicine
    Avian type C virus receptor research, Dr. Charles Moldow
  • 1975-1978
    Medicine Internship and Residency, University of Utah Medical Center, Salt Lake City
  • 1978-1979
    Clinical Fellow in Hematology/Oncology, University of California, San Francisco
    Clinical research conducted with Dr. Michael Friedman on therapy of hepatic tumors
  • 1979-1981
    Research Fellow in Hematology/Oncology, University of California, San Francisco
    Research conducted in the laboratory of Dr. Jay A. Levy studying mechanisms controlling infection with xenotropic type C retroviruses
  • 1981-1986
    Assistant Professor of Medicine, University of California, San Francisco
  • 1981-present
    Chief, Medical Oncology Division, San Francisco General Hospital
  • 1984-present
    Director, AIDS Program, San Francisco General Hospital
  • 1986-1990
    Associate Professor of Medicine, University of California, San Francisco
  • 1988-present
    Director, Center for AIDS Research, University of California, San Francisco
  • 1990-present
    Professor of Medicine, University of California, San Francisco
  • 1994-present
    Full Member, Cancer Center, University of California, San Francisco
  • 1997
    Program Leader, HIV Malignancies Research Program, UCSF Comprehensive Cancer Center
  • 2001-present
    Vice Chair, Department of Medicine, University of California, San Francisco
  • 2001-present
    Chief of the Medical Service, San Francisco Veterans Affairs Medical Center

Honors & Awards

  • 1986-1987
    National Academy of Sciences (Institute of Medicine) AIDS Policy Review Steering Committee
  • 1986-1987
    American Medical Association AIDS Panel
  • 1986-1988
    NIH AIDS Drug Selection Committee Member
  • 1986-1988
    National Institutes of Allergy and Infectious Disease AIDS Clinical Trials Group Executive Committee
  • 1987-1990
    National Academy of Sciences (Institute of Medicine) AIDS Activities Oversight Committee
  • 1990-1992
    International AIDS Society, President
  • 1992-1993
    Co-chair Institute of Medicine Round Table on AIDS Drug and Vaccine Development
  • 1993-present
    Founder and Board Chair, International AIDS Society - USA, Inc.
  • 1994-present
    National Policy Advisory Board for the HIV Cost and Services Utilization Study, RAND
  • 1997-present
    HIV Research Agenda Committee, AIDS Clinical Trials Group
  • 1998-present
    Interim Review Committee, ACTG 372
  • 1998-present
    Interim Review Committee, ACTG 368
  • 1998-present
    Center for AIDS Research Directors' Group, Chair
  • 1999-present
    Institute of Medicine

Selected Publications

  1. Volberding P. HIV Cure: The Target Is Clearer but Not Yet Close. Ann Intern Med. 2014 Apr 1; 160(7):505-6.
    View on PubMed
  2. Volberding PA. Solving the mystery of JAIDS. J Acquir Immune Defic Syndr. 2013 Aug 1; 63(4):417.
    View on PubMed
  3. Das M, Volberding P. Bringing the end in sight: consensus regarding HIV screening strategies. Ann Intern Med. 2013 Jul 2; 159(1):63-4.
    View on PubMed
  4. El-Sadr WM, Morrison JS, Quinn T, Volberding P. A chronicle of hope and promise: the world as it was, as it is, and as it can be. J Acquir Immune Defic Syndr. 2012 Aug 15; 60 Suppl 3:S49-50.
    View on PubMed
  5. Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, Cahn P, Eron JJ, Günthard HF, Hammer SM, Reiss P, Richman DD, Rizzardini G, Thomas DL, Jacobsen DM, Volberding PA. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012 Jul 25; 308(4):387-402.
    View on PubMed
  6. High KP, Brennan-Ing M, Clifford DB, Cohen MH, Currier J, Deeks SG, Deren S, Effros RB, Gebo K, Goronzy JJ, Justice AC, Landay A, Levin J, Miotti PG, Munk RJ, Nass H, Rinaldo CR, Shlipak MG, Tracy R, Valcour V, Vance DE, Walston JD, Volberding P. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012 Jul 1; 60 Suppl 1:S1-18.
    View on PubMed
  7. Brown B, Henry K, Volberding P. A clinical view: a trio of HIV specialists offer their take on HIV--then, now, and in the future. Interview by Heidi M Nass. Posit Aware. 2012; 24(4):2-5.
    View on PubMed
  8. Volberding P. The impact of HIV research on health outcome and healthcare policy. Ann Oncol. 2011 Nov; 22 Suppl 7:vii50-vii53.
    View on PubMed
  9. Connick E, Bosch RJ, Aga E, Schlichtemeier R, Demeter LM, Volberding P. Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection. J Acquir Immune Defic Syndr. 2011 Sep 1; 58(1):1-8.
    View on PubMed
  10. Tabas JA, Boscardin C, Jacobsen DM, Steinman MA, Volberding PA, Baron RB. Clinician attitudes about commercial support of continuing medical education: results of a detailed survey. Arch Intern Med. 2011 May 9; 171(9):840-6.
    View on PubMed
  11. Martin J, Volberding P. HIV and premature aging: A field still in its infancy. Ann Intern Med. 2010 Oct 5; 153(7):477-9.
    View on PubMed
  12. Dykes C, Mukherjee AL, Bosch RJ, Connick E, Volberding PA, Demeter LM. Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371. J Acquir Immune Defic Syndr. 2010 Sep; 55(1):132-4.
    View on PubMed
  13. Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, Gatell JM, Günthard HF, Hammer SM, Hirsch MS, Jacobsen DM, Reiss P, Richman DD, Volberding PA, Yeni P, Schooley RT. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010 Jul 21; 304(3):321-33.
    View on PubMed
  14. Volberding PA, Deeks SG. Antiretroviral therapy and management of HIV infection. Lancet. 2010 Jul 3; 376(9734):49-62.
    View on PubMed
  15. Choi AI, Li Y, Parikh C, Volberding PA, Shlipak MG. Long-term clinical consequences of acute kidney injury in the HIV-infected. Kidney Int. 2010 Sep; 78(5):478-85.
    View on PubMed
  16. Choi AI, Li Y, Deeks SG, Grunfeld C, Volberding PA, Shlipak MG. Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation. 2010 Feb 9; 121(5):651-8.
    View on PubMed
  17. Linzer M, Warde C, Alexander RW, Demarco DM, Haupt A, Hicks L, Kutner J, Mangione CM, Mechaber H, Rentz M, Riley J, Schuster B, Solomon GD, Volberding P, Ibrahim T. Part-time careers in academic internal medicine: a report from the association of specialty professors part-time careers task force on behalf of the alliance for academic internal medicine. Acad Med. 2009 Oct; 84(10):1395-400.
    View on PubMed
  18. Volberding P, Demeter L, Bosch RJ, Aga E, Pettinelli C, Hirsch M, Vogler M, Martinez A, Little S, Connick E. Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment. AIDS. 2009 Sep 24; 23(15):1987-95.
    View on PubMed
  19. Volberding P. Cohorts, trials, and evidence: expanding our confidence in guidelines for antiretroviral resistance testing. Ann Intern Med. 2009 Jul 21; 151(2):135-6.
    View on PubMed
  20. Hammer SM, Eron JJ, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008 Aug 6; 300(5):555-70.
    View on PubMed

Go to UCSF Profiles, powered by CTSI